Results 11 to 20 of about 1,451,429 (415)

Nasopharyngeal Myoepithelial Carcinoma Mimicking Nasopharyngeal Carcinoma [PDF]

Journal of Cancer Research and Practice, 2006
Myoepithelial carcinoma (malignant myoepithelioma) (MC) is a rare tumor, defined as a malignant salivary neoplasm composed almost exclusively of tumor cells with myoepithelial differentiation.
Boekholdt, S M, Doevendans, P A, Hovingh, G K, Jansen, H, Jukema, J W, Kastelein, J J P, Kuivenhoven, J A, Peters, R I G, Reitsma, P H, Schiffers, P M H, Souverein, O W, Tanck, M W T, van der Wall, E E, Zwinderman, A H   +13 more
core   +5 more sources

Nasopharyngeal carcinoma in children [PDF]

Cancer, 1976
Ten children with lymphoepithelioma of the nasopharynx were reviewed. Six had regional spread at presentation and four developed distant metastases. Seven patients are alive, six free of disease. The 5-year survival rate was 62.5% of this series. Five patients presented later with endocrine abnormalities probably related to the radiotherapy; these ...
C. Hernández Fernández, Ayten Cangır, Naguib A. Samaan, Roberto Rivera   +3 more
openalex   +4 more sources

Nasopharyngeal carcinoma [PDF]

The Lancet, 2005
Incidence of nasopharyngeal carcinoma has remained high in endemic regions. Diagnosing the disease in the early stages requires a high index of clinical acumen and, although most cross-sectional imaging investigations show the tumour with precision, confirmation is dependent on histology.
Wei, WI, Sham, JST
openaire   +7 more sources

Nasopharyngeal carcinoma in situ in nasopharyngeal carcinoma. [PDF]

Journal of Clinical Pathology, 1992
AIMS: To assess the presence of carcinoma in situ (CIS) in patients with nasopharyngeal carcinoma (NPC) and to see if the number of biopsy sites facilitates detection of CIS. METHODS: Formalin fixed, paraffin wax embedded biopsy specimens (n = 285) from 187 patients with NPC in 1987 were studied for the presence of CIS as well as for the histological ...
Chan, CW, Choy, D, Sham, JST, Dickens, P, Nicholls, JM   +4 more
openaire   +4 more sources

Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

JAMA Oncology, 2022
This multicenter, open-label randomized clinical trial conducted in China compares the efficacy and safety of adjuvant capecitabine with concurrent chemoradiotherapy vs concurrent chemoradiotherapy alone for treatment of patients with locoregionally ...
J. Miao, Lin Wang, S. Tan, Jin-Gao Li, J. Yi, E. Ong, L. Y. Tan, Ye Zhang, X. Gong, Qiu-Yan Chen, Yan-Qun Xiang, Ming-Yuan Chen, Ying Guo, X. Lv, W. Xia, Linquan Tang, Xiaowu Deng, Xiang Guo, F. Han, H. Mai, M. Chua, Chong Zhao   +21 more
semanticscholar   +1 more source

Accumulated Dose Deviation of Rotational and Residual Setup Errors on Nasopharyngeal Carcinoma Using MIM Treated by Helical Tomotherapy

Technology in Cancer Research & Treatment, 2023
Background To analyze the relationship between the rotational and residual setup errors and the dose deviation on nasopharyngeal carcinoma (NPC) treated by helical tomotherapy (HT).
Wenyan Yao MS, Jiang Hu MS, Peixun Xu BS, Mengxue He MS, Yongwen Fang BS, Mingzhi Liu BS, Zongtai Li BS, Huilang He MS, Hui Liu MS, Wenzhao Sun PhD, Senkui Xu MS   +10 more
doaj   +1 more source

Unique case of inverted papilloma of septum with nasopharyngeal carcinoma:Is it a metachronous tumour? [PDF]

, 2020
Inverted papilloma is a rare and benign tumour. It affects the nasal cavity and paranasal sinuses, has a high rate of recurrence and is associated with malignant transformation.
Ferguson, Aaron S. J., Flach, Susanne, Manickavasagam, Jaiganesh, White, Paul S., White, Sharon   +4 more
core   +3 more sources

Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1

Cancer Research, 2021
This work demonstrates that circBART2.2 binding to RIG-I is essential for the regulation of PD-L1 and subsequent immune escape in nasopharyngeal carcinoma.
Junshang Ge, Jie Wang, F. Xiong, Xianjie Jiang, Kunjie Zhu, Yian Wang, Yongzhen Mo, Zhaojian Gong, Shanshan Zhang, Yi He, Xiayu Li, Lei Shi, Can Guo, Fuyan Wang, Ming Zhou, Bo Xiang, Yong Li, Gui-yuan Li, Wei Xiong, Zhaoyang Zeng   +19 more
semanticscholar   +1 more source

Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape

Nature Communications, 2021
Interplay between EBV infection and acquired genetic alterations during nasopharyngeal carcinoma (NPC) development remains vague. Here we report a comprehensive genomic analysis of 70 NPCs, combining whole-genome sequencing (WGS) of microdissected tumor ...
J. Bruce, K. To, V. Lui, G. T. Chung, Y. Chan, C. Tsang, K. Yip, B. Ma, J. Woo, E. Hui, Michael K F Mak, S. Lee, C. Chow, S. Velapasamy, Yvonne Y Y Or, Pui Kei Siu, Samah El Ghamrasni, S. Prokopec, Man Wu, J. S. Kwan, Yuchen Liu, J. Chan, C. van Hasselt, L. Young, C. Dawson, I. Paterson, L. Yap, S. Tsao, Fei-Fei Liu, A. Chan, Trevor J Pugh, K. Lo   +31 more
semanticscholar   +1 more source

Radiomics in Nasopharyngeal Carcinoma [PDF]

Clinical Medicine Insights: Oncology, 2022
Nasopharyngeal carcinoma (NPC) is one of the most common head and neck malignancies, and the primary treatment methods are radiotherapy and chemotherapy. Radiotherapy alone, concurrent chemoradiotherapy, and induction chemotherapy combined with concurrent chemoradiotherapy can be used according to different grades. Treatment options and prognoses vary
Wenyue Duan, Bingdi Xiong, Ting Tian, Xinyun Zou, Zhennan He, Ling Zhang   +5 more
openaire   +3 more sources